GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Manhattan Scientifics Inc (OTCPK:MHTX) » Definitions » 3-Year ROIIC %

MHTX (Manhattan Scientifics) 3-Year ROIIC % : 0.48% (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Manhattan Scientifics 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Manhattan Scientifics's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 0.48%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Manhattan Scientifics's 3-Year ROIIC % or its related term are showing as below:

MHTX's 3-Year ROIIC % is ranked better than
52.68% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: -1.765 vs MHTX: 0.48

Manhattan Scientifics 3-Year ROIIC % Historical Data

The historical data trend for Manhattan Scientifics's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Manhattan Scientifics 3-Year ROIIC % Chart

Manhattan Scientifics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -104.10 -36.56 160.21 -49.50 0.48

Manhattan Scientifics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.48 - -

Competitive Comparison of Manhattan Scientifics's 3-Year ROIIC %

For the Medical Devices subindustry, Manhattan Scientifics's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Manhattan Scientifics's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Manhattan Scientifics's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Manhattan Scientifics's 3-Year ROIIC % falls into.



Manhattan Scientifics 3-Year ROIIC % Calculation

Manhattan Scientifics's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -0.703 (Dec. 2023) - -0.675 (Dec. 2020) )/( 0.317 (Dec. 2023) - 6.183 (Dec. 2020) )
=-0.028/-5.866
=0.48%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Manhattan Scientifics  (OTCPK:MHTX) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Manhattan Scientifics 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Manhattan Scientifics's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Manhattan Scientifics Business Description

Traded in Other Exchanges
N/A
Address
244 Fifth Avenue, Suite 2341, New York, NY, USA, 10001
Manhattan Scientifics Inc is a company operating as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in the areas of nano-technologies and nano-medicines. The company continues to identify emerging technologies through strategic alliances with scientific laboratories, educational institutions, and scientists and leaders in industry and government. Its current focus is on the development of nanomaterials through the acquisition of Metallicum.
Executives
Chris Theoharis director 405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Photios Frank Georgiou director 405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Emmanuel Tsoupanarias director, officer: Chief Executive Officer 405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Leonard Friedman director 405 LEXINGTON AVENUE, 26TH FLOOR, NEW YORK NY 10174
Marvin Maslow director, 10 percent owner, officer: Chief Executive Office MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022
David Teich director, officer: Treasurer MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022
Ralph Anderson director 641 FIFTH AVENUE SUITE 36F, NEW YORK NY 10022
Larry H Schatz director 152 W. 57TH STREET, 31ST FLOOR, NEW YORK NY 10019
Marty Steinberg 10 percent owner 1111 BRICKELL AVENUE SUITE 2500, MIAMI FL 33131
Scott Bach director, officer: Secretary MANHATTAN SCIENTIFICS INC, 541 FIFTH AVE STE 36F, NEW YORK NY 10022

Manhattan Scientifics Headlines

No Headlines